SAM
ABUS icon

Smartleaf Asset Management’s Arbutus Biopharma ABUS Stock Holding History

Smartleaf Asset Management’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.43K Hold
1,729
– – ﹤0.01% 2462
2025
Q4 		$7.99K Hold
1,729
– – ﹤0.01% 2484
2025
Q3 		$7.71K Buy
1,729
+107
+7% +$393 ﹤0.01% 2214
2025
Q2 		$5.08K Buy
1,622
+78
+5% +$259 ﹤0.01% 2044
2025
Q1 		$5.4K Sell
1,544
-1,144
-43% -$3.81K ﹤0.01% 2159
2024
Q4 		$8.6K Buy
2,688
+862
+47% +$3.17K ﹤0.01% 2050
2024
Q3 		$6.99K Buy
1,826
+1,084
+146% +$4.16K ﹤0.01% 1967
2024
Q2 		$2.3K Buy
+742
New +$2.23K ﹤0.01% 2176

Other funds holding ABUS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Smartleaf Asset Management's ABUS Position: Q1 2026 in Review

Smartleaf Asset Management held its Arbutus Biopharma (ABUS) position steady in Q1 2026 at 1,729 shares worth $7.43K. The position accounts for ﹤0.01% of the portfolio, ranked #2462.

Smartleaf Asset Management first reported a position in ABUS in Q2 2024 and has held it in 8 quarters since. The position peaked at $8.6K in Q4 2024. 167 funds tracked by Wall St. Rank hold ABUS as of Q1 2026.

  • Smartleaf Asset Management held 1,729 shares of Arbutus Biopharma worth $7.43K as of Q1 2026.
  • Smartleaf Asset Management left its Arbutus Biopharma share count unchanged in Q1 2026.
  • Arbutus Biopharma made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #2462 holding.
  • Smartleaf Asset Management first reported a position in Arbutus Biopharma in Q2 2024 and has held it in 8 quarters since.
  • Smartleaf Asset Management's Arbutus Biopharma position peaked at $8.6K in Q4 2024.
  • 167 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.